Digital Pathology Market - Global Industry Forecast 2025

Digital Pathology Market

- Opportunity Analysis and Industry Forecast 2016 - 2025

  • Date Medical Devices & Supplies
  • Date December 2016
  • price $3995
 
 

Digital Pathology Market Overview:


According to the study of expert market analysts, the digital pathology market is expected to register a significant CAGR in the period 2017–2025. Digital pathology is an image-based information platform that allows management, analysis, and interpretation of information generated from a digital slide. Due to the recent developments in pathology sector, digital pathology has become an emerging field. Furthermore, introduction of Whole-Slide Imaging in the field of digital pathology has exploded the market, and it is regarded as the most promising future of diagnostic medicine to achieve better, faster, and cheaper diagnosis of chronic diseases. The surge in the digital pathology market is due to the cost-effective procedures, ease in transportation, and high efficiency. As the images can be assessed by computer algorithms, it produces enhanced output in minimum time. In addition, the digital pathology offers low chances of errors in observation and interpretation. Therefore, the digital pathology is widely accepted over the conventional pathology. However, scarcity of skilled labor and adverse reimbursement policies hinders the digital pathology market.

Drivers and Restraints:

The growth of the digital pathology market is driven by the increased popularity of the virtual slides as compared to physical slides. In addition, the technological advancements and cost-effective products in the digital pathology have boosted the digital pathology market. Furthermore, analysis efficiency, workflow efficiency, and accuracy are some of the factors that increased the growth of the market. However, several factors such as shortage of reimbursement policies, pending product approvals, and mediocre infrastructure hinders the digital pathology market.


Key Segmentation:

By Type

  • Animal Digital Pathology
  • Human Digital Pathology

By Application

 
  • Disease Diagnosis
  • Tele consultation
  • Drug Discovery

By End User

  • Hospitals
  • Academic institutes
  • Pharmaceutical companies

By Region

  • North America
  • Asia-Pacific
  • Europe
  • LAMEA

Key Market Players:

The report profiles top players of the market to help understand their strategies to take advantage of the market. The key market players include Visiopharm, Definiens AG, Koninklinje Philips N.V., Hamamatsu Photonics K. K., Pixcelldata Ltd., Glencoe Software Inc., Indica Labs, Digipath Inc., Danaher Corporation (Leica Microsystem), PerkinElmer, Inc, and Nikon Corporation.

Key Takeaways from the Report:
  • The in-depth analysis of the digital pathology market presents vital information of the key factors that affect the dynamic of the market.
  • The digital pathology market report includes crucial information about drivers, restrains, and opportunities along with the impact analysis.
  • The digital pathology market and forecast are provided by closely monitoring the past and present market trends.
  • The digital pathology market report is an essential tool for organizations and business enthusiast to develop strong base of information of the market.
  • The report provides statistical knowledge to help market players to understand the market growth and trends.
  • A detailed study of the digital pathology market is offered based on geography to help understand the top investment regions.

CHAPTER 1 INTRODUCTION

1.1 Report description
1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 GLOBAL MARKET OVERVIEW

3.1 Market definition and scope
3.2 Introduction
3.3 Conventional pathology vs. digital pathology
3.4 Image analysis and data retrieval
3.5 Management systems in digital pathology
3.6 Global access to data
3.7 Clinical trials using digital pathology
3.8 Information systems in digital pathology
3.1 Key findings
3.1.1 Top winning strategies
3.1.2 Top investment pockets
3.1.2.1 digital pathology market by product
3.1.2.2 digital pathology market by end user
3.2 Porter’s five forces analysis
3.2.1 Competition reduces the power of the suppliers
3.2.2 Availability of wide range of products enhances the buyer’s power
3.2.3 Emerging market creates high competition
3.2.4 Cost factor lowers the threat of new entrants
3.2.5 High cost encourages substitution
3.3 Regulatory issues
3.4 Reimbursement scenario
3.5 Case study
3.5.1 Case study 1: Digital pathology used in critical diagnosis
3.5.2 Case study 2: Examples and initiatives of deploying telepathology in emerging economies
3.5.3 Case study 3: Role of digital pathology in saving cost of pharma companies
3.6 Market dynamics
3.6.1 Drivers
3.6.1.1 Use of digital pathology in cancer diagnosis
3.6.1.2 Cost-efficiency
3.6.1.3 Ease in transportation
3.6.1.4 High efficiency
3.6.1.5 Efficient analysis
3.6.1.6 System efficiency
3.6.1.7 Efficiency in workflow
3.6.1.8 Diagnosis in remote regions
3.6.2 Restraints
3.6.2.1 Lack in reimbursement
3.6.2.2 Lack of infrastructure in developing economies
3.6.2.3 Resistance towards adoption of digital pathology
3.6.3 Opportunities
3.6.3.1 Opportunities from emerging economies
3.6.3.2 Rising awareness pertaining to digital pathology
3.6.3.3 Increasing potential of digital pathology

CHAPTER 4 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCTS

4.1 Global digital pathology market, by product
4.2 Whole slide imaging (WSI)
4.2.1 Global Digital Pathology whole slide imaging market, by product
4.2.2 Global digital pathology whole slide imaging market
4.3 Image analysis—informatics
4.3.1 Drivers
4.3.1.1 Helps in decision making
4.3.1.2 Automation to analyze Multitude of images
4.3.1.3 Compare image data with other data
4.3.1.4 study complex morphologies and features
4.3.2 Global digital pathology image analysis—informatics market
4.4 Storage, communication, and information management systems
4.4.1 Global digital pathology information management system, storage, & communication market
4.5 Others
4.5.1 Global digital pathology others market, by geography

CHAPTER 5 DIGITAL PATHOLOGY MARKET, BY END USER

5.1 Global digital pathology market, by end user
5.2 Pharmaceutical and biotechnology companies
5.2.1 Global digital pathology pharmaceutical research market
5.3 Hospitals and diagnostic centers
5.3.1 Global digital pathology clinical organizations market
5.4 Educational institutes
5.4.1 Global digital pathology educational institutes market

CHAPTER 6 GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY

6.1 Overview
6.2 North America
6.2.1 North America digital pathology market
6.2.2 U.S. market size and forecast
6.2.3 Canada market size and forecast
6.2.4 Mexico market size and forecast
6.3 Europe
6.3.1 Europe digital pathology market
6.3.2 Germany market size and forecast
6.3.3 France market size and forecast
6.3.4 U.K. market size and forecast
6.3.5 Italy market size and forecast
6.3.6 Spain market size and forecast
6.3.7 Russia market size and forecast
6.3.8 Other Europe market size and forecast
6.4 Asia-Pacific
6.4.1 Asia-Pacific digital pathology market
6.4.2 Japan market size and forecast
6.4.3 China market size and forecast
6.4.4 Australia market size and forecast
6.4.5 India market size and forecast
6.4.6 South Korea market size and forecast
6.4.7 Taiwan market size and forecast
6.4.8 Other Asia-Pacific market size and forecast
6.5 LAMEA
6.5.1 LAMEA digital pathology market
6.5.2 Brazil market size and forecast
6.5.3 Turkey market size and forecast
6.5.4 Venezuela market size and forecast
6.5.5 Saudi Arabia market size and forecast
6.5.6 Colombia market size and forecast
6.5.7 Argentina market size and forecast
6.5.8 Other LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1 Visiopharm
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Key Strategic Moves & Developments
7.1.5 SWOT Analysis
7.2 Indica Labs
7.2.1 Company Overviewlogy, toxicological pathology, and more.
7.2.2 Company Snapshot
7.2.3 Operating Business Segments
7.2.4 Key Strategic Moves & Developments
7.2.5 SWOT Analysis
7.3 Digipath Inc.
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating Business Segments
7.3.4 Key Strategic Moves & Developments
7.3.5 SWOT Analysis
7.4 Koninklinje Philips N.V.
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating Business Segments
7.4.4 Business Performance
7.4.5 Key Strategic Moves & Developments
7.4.6 SWOT Analysis
7.5 Hamamatsu Photonics K.K.
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments
7.5.4 Business Performance
7.5.5 Key Strategic Moves & Developments
7.5.6 SWOT Analysis
7.6 PerkinElmer, Inc.
7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments
7.6.4 Business Performance
7.6.5 Key Strategic Moves & Developments
7.6.6 SWOT Analysis
7.7 Danaher Corporation (Leica Microsystem)
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating Business Segments
7.7.4 Business Performance
7.7.5 Key Strategic Moves & Developments
7.7.6 SWOT Analysis
7.8 Nikon Corporation
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating Business Segments
7.8.4 Business Performance
7.8.5 Key Strategic Moves & Developments
7.8.6 SWOT Analysis
7.9 Pixcelldata Ltd.
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating Business Segments
7.9.4 Key Strategic Moves & Developments
7.9.5 SWOT Analysis
7.10 Glencoe Software Inc.
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Key Strategic Moves & Developments
7.10.4 SWOT Analysis
7.11 Definiens AG
7.11.1 Company Overview
7.11.2 Company Snapshot
7.11.3 Key Strategic Moves & Developments
7.11.4 SWOT analysis

List of Figures

FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022–2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022–2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022–2027)
FIG. 4 DIGITAL PATHOLOGY MARKET DEFINITION
FIG. 5 TOP WINNING STRATEGIES IN THE DIGITAL PATHOLOGY MARKET (2013–2016)
FIG. 6 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2013–2016)
FIG. 7 TOP INVESTMENT POCKETS, BY PRODUCT
FIG. 8 TOP INVESTMENT POCKET BY END USER
FIG. 9 PORTER’S FIVE FORCES ANALYSIS
FIG. 10 TOP IMPACTING FACTORS: DIGITAL PATHOLOGY MARKET (2014–2022)
FIG. 11 DIGITAL PATHOLOGY WORKFLOW
FIG. 12 STORAGE WORKFLOW
FIG. 13 CLOUD STORAGE SYSTEM
FIG. 14 U.S. DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 15 CANADA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 16 MEXICO DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 17 GERMANY DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 18 FRANCE DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 19 U.K. DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 20 ITALY DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 21 SPAIN DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 22 RUSSIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 23 OTHER EUROPE DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 24 JAPAN DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 25 CHINA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 26 AUSTRALIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 27 INDIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 28 SOUTH KOREA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 29 TAIWAN DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 30 OTHER ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 31 BRAZIL DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 32 TURKEY DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 33 VENEZUELA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 34 SAUDI ARABIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 35 COLOMBIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 36 ARGENTINA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 37 OTHER LAMEA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
FIG. 38 VISIOPHARM - SWOT ANALYSIS
FIG. 39 INDICA LABS - SWOT ANALYSIS
FIG. 40 DIGIPATH INC - SWOT ANALYSIS
FIG. 41 PHILIPS HEALTHCARE: NET SALES, 2013–2015 ($MILLION)
FIG. 42 PHILIPS HEALTHCARE: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 43 KONINKLINJE PHILIPS N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 44 KLONINKINJE PHILIPS N.V. - SWOT ANALYSIS
FIG. 45 HAMATSU PHOTONICS K.K.: NET SALES, 2013–2015 ($MILLION)
FIG. 46 HAMATSU PHOTONICS K.K.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 47 HAMAMATSU PHOTONICS K.K. - SWOT ANALYSIS
FIG. 48 PERKINELMER, INC.: NET SALES, 2013–2015 ($MILLION)
FIG. 49 PERKINELMER INC.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 50 PERKINELMER INC.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 51 PERKINELMER INC. - SWOT ANALYSIS
FIG. 52 DANAHER: NET SALES, 2013–2015 ($MILLION)
FIG. 53 DANAHER: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 54 DANAHER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 55 DANAHER - SWOT ANALYSIS
FIG. 56 NIKON: NET SALES, 2013–2015 ($MILLION)
FIG. 57 NIKON: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 58 NIKON: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 59 NIKON - SWOT ANALYSIS
FIG. 60 PIXCELLDATA LTD. - SWOT ANALYSIS
FIG. 61 GLENCOE SOFTWARE INC - SWOT ANALYSIS
FIG. 62 DEFINIENS - SWOT ANALYSIS

List of Table

TABLE 1 GLOBAL DP PRODUCTS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 2 WORLD DP BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022–2027 ($MILLION)
TABLE 3 WORLD DP RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022–2027 ($MILLION)
TABLE 4 WORLD DP DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022–2027 ($MILLION)
TABLE 5 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 6 WHOLE SLIDE IMAGING SCANNERS BY VARIOUS COMPANIES
TABLE 7 GLOBAL DIGITAL PATHOLOGY WHOLE SLIDE IMAGING MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 8 GLOBAL DIGITAL PATHOLOGY WHOLE SLIDE IMAGING MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 9 IMAGE ANALYSIS SOFTWARE BY VARIOUS COMPANIES
TABLE 10 GLOBAL DIGITAL PATHOLOGY IMAGE ANALYSIS—INFORMATICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 11 GLOBAL DIGITAL PATHOLOGY INFORMATION MANAGEMENT SYSTEM, STORAGE & COMMUNICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12 GLOBAL DIGITAL PATHOLOGY OTHERS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 13 GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2014–2022 ($MILLION)
TABLE 14 GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 15 GLOBAL DIGITAL PATHOLOGY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 16 GLOBAL DIGITAL PATHOLOGY HOSPITALS AND DIAGNOSTIC CENTERS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 17 GLOBAL DIGITAL PATHOLOGY EDUCATIONAL INSTITUTES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 18 WORLD DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 19 NORTH AMERICA DIGITAL PATHOLOGY MARKET, 2014–2022 ($MILLION)
TABLE 20 EUROPE DIGITAL PATHOLOGY MARKET, 2014–2022 ($MILLION)
TABLE 21 ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2014–2022 ($MILLION)
TABLE 22 LAMEA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
TABLE 23 VISIOPHARM - COMPANY SNAPSHOT
TABLE 24 VISIOPHARM - OPERATING SEGMENTS
TABLE 25 INDICA LABS - COMPANY SNAPSHOT
TABLE 26 INDICA LABS - OPERATING SEGMENTS
TABLE 27 DIGIPATH INC - COMPANY SNAPSHOT
TABLE 28 DIGIPATH CORPORATION - OPERATING SEGMENTS
TABLE 29 KONINKLINJE PHILIPS N. V. - COMPANY SNAPSHOT
TABLE 30 PHILIPS HEALTHCARE - OPERATING SEGMENTS
TABLE 31 HAMAMTSU PHOTONICS K. K. - COMPANY SNAPSHOT
TABLE 32 HAMAMTSU PHOTONICS K.K. - OPERATING SEGMENTS
TABLE 33 PERKINELMER INC. - COMPANY SNAPSHOT
TABLE 34 PERKINELMER INC. - OPERATING SEGMENTS
TABLE 35 DANAHER - COMPANY SNAPSHOT
TABLE 36 DANAHER - OPERATING SEGMENTS
TABLE 37 NIKON - COMPANY SNAPSHOT
TABLE 38 NIKON - OPERATING SEGMENTS
TABLE 39 PIXCELLDATA LIMITED- COMPANY SNAPSHOT
TABLE 40 GLENCOE SOFTWARE - COMPANY SNAPSHOT
TABLE 41 DEFINIENS - COMPANY SNAPSHOT

License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Similar Market Research Report

blog
May
2018
United States Amniotic Membrane Market

The United States Amniotic Membrane Market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022. Read More >>

 

Get Email Alert